According to a recent LinkedIn post from Zorro, interest in Individual Coverage Health Reimbursement Arrangements (ICHRA) appears to have accelerated between 2024 and 2025, with the post citing adoption growth of 52% for small employers and 34% for large employers. The post also indicates that Zorro’s own user base expanded threefold during the 2026 open enrollment period.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post further notes that nearly half of benefits brokers are now actively selling ICHRA, with almost a quarter reportedly serving 11 or more ICHRA clients. In addition, 93% of brokers referenced in the post are described as expecting ICHRA adoption to rise over the next five years, suggesting continued structural growth in this benefits model.
For investors, this content points to a potentially expanding addressable market for Zorro’s platform if ICHRA continues to gain share versus traditional group health plans. The 3x user growth metric, if sustained or repeated, could translate into higher recurring revenue and improved operating leverage, though the post does not provide details on monetization, customer retention, or unit economics.
The emphasis on broker engagement may indicate that Zorro is increasingly integrated into intermediary distribution channels, which can support scalable customer acquisition but may also compress margins through commission or partnership structures. If ICHRA penetration proceeds as optimistically as the broker sentiment in the post suggests, competitive intensity and regulatory scrutiny in the space could increase, affecting Zorro’s long‑term pricing power and differentiation.
Overall, the LinkedIn post portrays ICHRA as moving from a niche solution toward broader employer and broker adoption, positioning Zorro as a beneficiary of this trend. Investors evaluating Zorro’s outlook may want to track whether reported user and market adoption trends translate into sustained revenue growth, as well as how effectively the company can defend share as the ICHRA market matures.